Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer - A Pilot Study
This pilot study hypothesizes that hyperthermia delivered via magnetic resonance-guided
focused ultrasound (MRg-FU) is technically feasible and can be safely used in combination
with concurrent reirradiation and chemotherapy for the treatment of recurrent rectal cancer.
Twenty recurrent rectal cancer patients who are not candidates for surgery will be recruited
for hyperthermia treatment delivered via MRg-FU concurrent with reirradiation and oral
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society